Financial PerformanceRubicon reported Q3 financial results that beat analyst estimates, with revenue coming in at $15.6M, showing a 16% year-over-year increase.
Market ExpansionRubicon's newly acquired Cascadia facility has received its Health Canada license, positioning the company for further growth.
Market Share GrowthRubicon's national market share of flower and pre-rolls increased slightly, and it achieved the #3 position in premium vapes with 13.2% market share.